Elana Thieme and Mark Mendoza, fourth-year graduate students in the Molecular and Cell Biology (MCB) PhD Program jointly ...

Ernexa is advancing a best-in-class approach using synthetic, allogeneic iMSCs to provide a scalable, off-the-shelf treatment without needing patient-specific cell harvesting. The Company continues to ...

How OEMs benefit from accelerated custom rupture disk prototyping through coordinated development & advanced engineering ...

A combination of two therapies, azacitidine and venetoclax, or aza-ven, outperformed intensive chemotherapy for acute myeloid leukemia in patients healthy enough to receive aggressive treatment, ...

When visionary entrepreneur and investor David Roja joined The Rhonda Swan Show: Wake Up New York City Edition on Wall Street ...

Strengthening the company’s ability to deliver reliable and grid-ready utility-scale energy storage systems worldwide ...

The standard measure of lesion count may matter less than the underlying biology driving treatment response in ...

It took decades for the ELN to achieve hegemony in Arauca. Recently, it has solidified a similar level of control on the ...

SoftBank is reportedly in talks to acquire infrastructure investor DigitalBridge in a deal that would be all about riding the ...

Information on admissions, scholarships, new courses, research studies and other events at schools and colleges ...

With a four-year, $3.2 million grant from the National Institutes of Health, a team from Pen State College of Medicine will ...

With revenue and profit surging in the first half of the year, an order book approaching 5 GW, and a new integrated plant ...